Federal study gives new options for people with rare cancers

People with rare cancers have been out of luck—not only do most lack good treatments but drug companies also don’t pursue them because of small potential sales. Now, a federal study that pools these folks gives them strength in numbers and new options. The first results from this novel effort were revealed at an American Association for Cancer Research conference […]

Read more

Women scientists get less federal funding than men, new study finds

First-time women principal investigator scientists received considerably less funding from the National Institutes of Health (NIH) compared to first-time male principal investigators, even at top research institutions, reports a new study from Northwestern Medicine and the Kellogg School of Management. Previous research showed women receive lower startup funds from their universities to launch their research. This is the first study […]

Read more

High-strength opioid formulations: The case for the federal minister of health to recall them

One regulatory tool that has yet to be deployed to curb the ongoing opioid epidemic is the power of the federal minister of health to recall high-strength opioid formulations from the market. These opioid formulations can harm patients with chronic pain in multiple ways and the minister could recall them, argues a commentary in CMAJ (Canadian Medical Association Journal). “In […]

Read more